Wave Life Sciences, Inc. SEC filings WVE
Wave Life Sciences, Inc. has 743 filings in SEC EDGAR's recent list, going back to Feb 2, 2015. Its latest annual report, Form ARS, was filed on Oct 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 14, 2026 | — |
| 15-12G | Deregistration | Aug 10, 2026 | — |
| POSASR | Filing | Aug 10, 2026 | — |
| 8-K12B | Filing | Aug 7, 2026 | Aug 7, 2026 |
| UPLOAD | Letter from the SEC | May 5, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| PRER14A | Filing | May 1, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2026 | — |
| EFFECT | Filing | May 4, 2022 | — |
| CORRESP | Letter to the SEC | May 2, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2022 | — |
| EFFECT | Filing | May 1, 2020 | — |
| POSASR | Filing | Mar 2, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2019 | — |
| CORRESP | Letter to the SEC | Dec 3, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2019 | — |
| EFFECT | Filing | Aug 14, 2019 | — |
| CORRESP | Letter to the SEC | Aug 12, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2019 | — |
| CT ORDER | Filing | Sep 17, 2018 | — |
| CT ORDER | Filing | Jun 5, 2018 | — |
| EFFECT | Filing | Feb 6, 2017 | — |
| CORRESP | Letter to the SEC | Feb 2, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2017 | — |
| CT ORDER | Filing | Oct 4, 2016 | — |
| CT ORDER | Filing | Nov 16, 2015 | — |
| CERTNAS | Auto-generated paper document | Nov 12, 2015 | — |
| EFFECT | Filing | Nov 10, 2015 | — |
| 8-A12B | Form 8-a12b | Nov 9, 2015 | — |
| CORRESP | Letter to the SEC | Nov 6, 2015 | — |
| CORRESP | Letter to the SEC | Nov 6, 2015 | — |
| CORRESP | Letter to the SEC | Oct 23, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2015 | — |
| DRS/A | Filing | Oct 2, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2015 | — |
| DRS/A | Filing | Sep 17, 2015 | — |
| DRSLTR | Filing | Sep 16, 2015 | — |
| DRS | Filing | Sep 4, 2015 | — |
| D | Filing | Aug 28, 2015 | — |
| D | Filing | Feb 2, 2015 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- WVE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1631574
- Former names
- Wave Life Sciences Ltd. (until Jul 30, 2026); Wave Life Sciences LTD. (until Jul 30, 2026); WAVE Life Sciences Ltd. (until Jul 30, 2026); Wave Life Sciences Pte Ltd (until Nov 2, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.